In: International Journal of Public Health, 2015, vol. 60, no. 7, p. 753-754
|
In: International Journal of Public Health, 2015, vol. 60, no. 8, p. 999-1000
|
In: International Journal of Public Health, 2015, vol. 60, no. 6, p. 631-632
|
In: The Journal of Infectious Diseases, 2016, vol. 213, no. 5, p. 794-799
|
In: Pharmaceutical Research, 2015, vol. 32, no. 10, p. 3201-3212
|
In: International Journal of Public Health, 2015, vol. 60, no. 7, p. 757-759
|
In: Annual Review of Immunology
P. falciparum remains a serious public health problem and a continuous challenge for the immune system due to the complexity and diversity of the pathogen. Recent advances from several laboratories in the characterization of the antibody response to the parasite have led to the identification of critical targets for protection and revealed a new mechanism of diversification based on the...
|
In: The Journal of Immunology, 2020, vol. 204, no. 7, p. 1798–1809
Plasmodium spp., the causative agent of malaria, have a complex life cycle. The exponential growth of the parasites during the blood stage is responsible for almost all malaria-associated morbidity and mortality. Therefore, tight immune control of the intraerythrocytic replication of the parasite is essential to prevent clinical malaria. Despite evidence that the particular lymphocyte subset ...
|
In: Molecules, 2019, vol. 24, no. 12, p. 2310
We have explored the possibility of using organometallic derivatives of cobalamin as a scaffold for the delivery of the same antimalarial drug to both erythro- and hepatocytes. This hybrid molecule approach, intended as a possible tool for the development of multi-stage antimalarial agents, pivots on the preparation of azide- functionalized drugs which, after coupling to the vitamin, are...
|
In: International Journal of Public Health, 2014, vol. 59, no. 5, p. 679-680
|